Posts tagged "empowerment"

Just back from a really inspiring evening held by a client for 250 pharmacists at Wembley Stadium.

Alongside chicken satay and chardonnay was a really fresh approach.

Half way between stand-up and business school the slide presentation avoided a focus on products, ingredients, features or benefits. And elevated the discussion to value and driving an understanding that customer satisfaction was the common ground that existed between the audience and organisers.

The two hour presentation waxed lyrical on the value placed by customers on the interaction and the urgent requirement for pharmacy to wake up to engaging their customers in the non product elements of the consultation.

Delivered in a fresh, unusual and pretty compelling way it’s the first time I have seen this challenging approach and style of presentation given live with customers on a mature brand.

It’s pretty common to train and educate on launch brands during a med ed’ phase, but this focused on Business ed’ and went down a storm.  It provided a real opportunity for the company to demonstrate commercial expertise, partnership . Probably most importantly  it elevated the discussion from product flogging to a genuine adult to adult dialogue. A business talking to another business for mutual gain, rather than supplier and stockist fulfilling the usual adult child  cliché.

I hope to be able to get some footage to show you.

I have been contemplating a pitch Shep’ and I did last week  that for a first-time-for-us covered ‘prosumption’ as part of an approach to develop digital understanding and better resources.

In is woolliest form prosumption is useful when we are developing materials for a sub group of consumers when you just can’t follow the traditional; write/art direct/code/build, test, review and rebuild approach. Whether than be for time or budget reasons.

Prosumption is the mixing of  consumer and the producer to produce a new hybrid – the Prosumer. In what (another new word for me this week) I now know to be a portmanteau – a blend of two words and their meaning.

Reading around what I thought was a new internet thing. I find it’s almost as old as Ian, and much older than I am. In 1972, Marshall McLuhan and Barrington Nevitt suggested that technology would drive the consumer to become a producer (‘democratisation of media’ -  I hear Gemma (AD at AMV) shout). In the 1980 book, the term was coined by a futurologist named  Alvin Toffler who predicted this coming together.

The approach results in individuals working together blurring the barriers, between need for something and capability to provide it.

The conclusion of much of this work is that once mass market saturation and standardisation have brought us all happi(ish)ness, the market evolves  to initiate a process of mass customization. Giving consumers exactly what’s wanted with the assumption that this delivers a risk free relationship and a guaranteed happy customer.

Pretty interesting? It does make you think that once we all have perfectly tailored good, where will we go next? Ultimate rebellion should see us go full circle and start buying goods at George at ASDA perhaps?

Anyway fairly standardised fingers are crossed here. We hear Wednesday this week.

PS. I am really trying to avoid puns in headlines. Really sorry.

Ian handed me a fascinating article on ‘Should patients be paid for taking their medication?’. (He also said it was high time I wrote a blog. )The story described a trial where patients with mental illness were paid £15 for each fortnightly visit to their clinic where they were administered their depot.

My immediate answer was to say, of course they bloody shouldn’t be paid! Treatments are prescribed to make people feel better and help them function in the world, surely that is incentive enough?

Hold on, I thought – it’s plainly not enough. Poor compliance is a fact of mental healthcare. It’s easy to speculate on why these patients would avoid their medication. We need to ask about the conversations they are having with their HCPs. Are professionals helping patients reach an informed decision about treatments?

Well, at least one survey says not really. Here, 59% of patients taking an antipsychotic reported that other treatment options had not been discussed. Almost two thirds said that they hadn’t been given written information prior to starting their medication. And 46% said hey hadn’t been warned about its potential side effects.

The NHS and HCPs need to look at the way they are engaging with patients. How many have read the NICE guidance on patient adherence and choice, published in January? And how is the NHS supporting them in implementing change?

Of course, it’s not easy for anyone. The befuddling thing about informed choice is that patients can refuse medication, and the professional’s obligation is to respect this decision. But what if the individual is antisocial, or a danger to self or others? Why are we paying these guys, really – what are the savings down the line? To make a judgment on this pilot, we need to know more about these patients other than that they are poor compliers.

If the scheme sees the light, bitter laughter will accompany jokes about kids being paid to go to school and likewise to adults for behaving on a night out. No-one’s going to like the idea of a pay-for-peace society. Whatever happens, let’s hope these patients get something positive out of it.

Our ever loving ears hearken once more to the digital pitter patter of patient empowerment.  UCB Pharma have partnered with patientslikeme.com to bring an Epilepsy community to the site.

Patientslikeme.com is a privately owned initiative that encourages patients to post details about themselves. This real world, outcome-based data is shared with individuals and organisations who work to improve health outcomes, including pharmaceutical companies, research organizations, and non-profits.

30% of epilepsy patients are refractory to treatment, so this move is good news for patients, HCPs and even competing Pharma. Over 37,000 patients are already registered on the site as well as 3,000 caregivers. Any epilepsy community should include the voice of caregivers, as a significant proportion of epilepsy sufferers are elderly or have learning disabilities.

Patientslikeme.com doesn’t just collect data from patients, it provides quality information and allows them to blog and communicate with peers. It’s a site that really does seem to have patients’ interest at heart. That’s why we like it – and so congratulate UCB for being a part.

Recently, I had the privilege of attending a conference where William Burns, CEO of Roche was speaking.

The thing I found most fascinating was his future view: “the patient of tomorrow will be in the driving seat”.

As he says, today’s patients research via the net to talk to other patients about which trials, medicines, doctors and hospitals might be best for them. They then make informed decisions and requests based on this and will argue with multiple gatekeepers to get there.

I’m interested to know other doctors views on this….Should an informed patient be feared or encouraged?

Although many people on this side of the Atlantic feel that the US Direct to Consumer advertising has taken things too far (and I would definitely agree) I do think there is more that should be done with Direct to Patient communication.

The internet is a great leveller given that everyone can put content on it, and increasingly acts as a first stop for many patients. But it does seem bizarre that in the UK, the pharma industry, who have access to the most information on products, are prevented from joining that discussion.

A couple of stats Mr Burns gave us made me think….

• 33% of the public use the internet prior to a doctor’s appointment
• 40% of the public will do so after a doctor’s appointment

Hopefully, the current EMEA debate on DTP communication will mean industry is more able to contribute in future.

I was once told across a crowded meeting room that maintaining the divide between business and personal life is important. “It’s business, not personal” still rings in my ears today.

Now I am part of our own agency, I feel I can stand back with a little more authority and give thought to this mantra.

The idea that what I do during the ‘day job’ is very different to who I am on the weekend, is one I have at times aspired to but never really succeeded at. I find it impossible not to be worried at home by worrying office stuff, or for a successful workday not to give me the foundation for a great evening out with my mates. Thus far the flick of the switch on the No. 38 to Angel has eluded me.

The strongest and best relationships we have are ones where we allow ourselves to be human, working alongside other humans, who worry, laugh, err and create… whether that’s at home discussing broad beans or striving for patient-integrated Rx strategy.

Being ourselves and keeping it personal was built into the agency culture from our earliest plans. The business side made Barclays happy and ensured we had rigour and efficiency. But by valuing personality we don’t break people down and rebuild them the ‘hive’ way, or force a process on a relationship. All actors are free to contribute ‘their’ way adding to what we are as an organisation.

What we want most is for people to say that we understand them at a personal level: what they want, where they plan to be, what they love, what they don’t – not just the business of the brand, political situation and process.

Because of this our business could never be anything other than personal.

A Cambridge University academic is leading a call to dispense with medical jargon in favour of everyday language. Dr Melinda Lyons claims in the Lancet that patients can get dangerously confused by unfamiliar and similar-sounding terms (intra vs inter; hypo vs hyper), particularly in stressful and noisy situations.

This is something to be grateful for, because it’s more proof that healthcare is becoming more patient-focused. While not without its challenges, communication built on the needs and expectations of the end user is clearly the way forward. Dr Lyons’ work, and the fact her research featured in the morning Metro, reminds us that everyone has a stake and a growing interest in what happens in the healthcare world.

But it also reminds us that people aren’t the same. Words that are necessary to one person may patronise another. At Hive we play our part by first understanding who the end user is. Only then can we get the dialogue right between that person and the person looking after them. We do this by letting the HCP know more about who’s in front of them.

It’s a subtle thing, joining the dots between different mentalities and creating proper engagement, but it’s not new in marketing. Without the correct delicacy however, you get a fumbling disaster which tries too hard and fails.

So, between the patronising and the ancient Greek, lies a tone of voice that resonates. Finding it is a beautiful thing.

A recent comment from a client made me think about how pharmacists act as brand enhancers for patients/consumers.

Pharmacists are highly educated healthcare professionals. Patients have long relied on their valuable skills and used their advice to make a purchase. However, it has been traditional for organisations to communicate with them principally in business terms. This retail-led approach creates dissonance between the relationship pharmacy has with a brand’s manufacturers and the one they have with the brand’s users.

The new Contract, however, changes things. Although the uptake of enhanced services seemed slow to begin with, pharmacy’s growing relationship with patients is now much in evidence. (As it is with other HCPs: the growing weight of pharmacy has strengthened links with prescribers.) With almost 2 years since the independent prescriber act, there are far better opportunities to be had than talking “stock pressure and profit on return”.

Instead, manufacturers who understand and enhance the close relationship between pharmacist and consumer will gain more end-user engagement. A recent study showed that when pharmacists intervened in the sale – not by recommending, but by providing an informed brand initiation – patient compliance increased and patients were more likely to make a repeat purchase. Proof that what can be good for profits can be great for patients.

As the professional identity of the pharmacist sinks in, their challenges revolve around setting the clinical scene and promoting new services to patients. Pharmaceutical companies must continue to track areas of progress and deliver a rounded offer that benefits in-house experts and their patients.

A recent post about the rise of the informed patient attracted some insightful comments. Dr J got me thinking about knowledge, responsibility and a few things in between.

Patient education is a good thing and we need more of it. The EMEA roadmap for 2010 promises more access to accredited medical information. Ideally this will help override the reams of flimsy information that, as Dr J points out, are in abundance.

I think the EMEA have their work cut out for them. How much information do people need for a start? Is it OK to broadcast an advert simply telling people to be more active, or do we need a clearer link to the real consequences of obesity? And what if we overload people with information – will we scare them into doing the wrong thing? Will they just stop listening?

What really alarmed me was Dr J’s comment that, even when patients know their onions, they often balk at decision time. Perhaps we know enough, but we’d still like to blame someone else if things don’t work out. Or is it the other way round – are we being urged to take more responsibility for our treatment, but don’t have enough insight to make decisions?

There’s a great take-out from this: We must be on the ball if our minds are boggling with the same question that patients’ are. What we all want to know is: how do we embrace patient empowerment without compromising medical integrity?

Looking forward to your thoughts on this one.